1. Hassig A, Lundsgaard-Hansen P: The procurement of blood and plasma for the production of components and derivatives within the frame of an integrated national blood program. Vox Sang, 1978; 34: 257–60.
2. Watt J: Epidemic hepatitis B caused by commercial human immunoglobulin. Lancet, 1979; 1: 1399–1400.
3. World Health Organisation. The collection, fractionation, quality control, and uses of blood and blood products. Geneva WHO, 1981.
4. Barker LF, Gerety RJ, Lorenz DE, Rastogi SC, Seligman EB: Biological standardization in viral hepatitis. In: Viral Hepatitis, Vyas GN, Cohen SN, Schmid R (eds). Philadelphia Franklin Institute Press, 1978: 581–87.
5. Zaia JA, Levin MJ, Preblud SR: The status of passive immunisation for herpes virus infections. In: Immunoglobulins: Characterisations and Uses of Intravenous Preparations, Alving BA, Finlayson JS (eds). United Sates Dept. of Health and Human Services, Washington D.C., 1980: 111–21.